How effective are medications in managing motor symptoms of Parkinson’s disease in Australia?

The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease. The creator of this program has divided into four segments to cover a complete plan to treat this disease along with improving your health and life by knowing everything about this health problem. The main focus of this program is on boosting the levels of hormone in your brain by making e a few easy changes in your lifestyle, diet, and thoughts

How effective are medications in managing motor symptoms of Parkinson’s disease in Australia?

Medications for managing motor symptoms of Parkinson’s disease in Australia are generally effective, particularly in the early and middle stages of the disease. The most commonly used medications include levodopa (often combined with carbidopa or benserazide), dopamine agonists, MAO-B inhibitors, and COMT inhibitors. These medications work by either increasing dopamine levels in the brain or mimicking dopamine’s effects, which helps to alleviate symptoms like tremors, rigidity, and bradykinesia (slowness of movement).

Effectiveness of Medications:

Levodopa is considered the most effective medication for controlling motor symptoms, particularly in the early stages of Parkinson’s disease. It helps improve motor control and reduces tremors and stiffness. However, long-term use can lead to complications like dyskinesia (involuntary movements), which may require adjustments in treatment.
Dopamine agonists (such as pramipexole and ropinirole) are often used in combination with levodopa or as monotherapy in early stages. They are generally effective in managing motor symptoms but may cause side effects like hallucinations and compulsive behaviors, especially in older adults.
MAO-B inhibitors (like selegiline and rasagiline) help extend the effects of dopamine in the brain and can be used alone or with other medications. They are effective in reducing “off” periods when symptoms return between doses of medication.
COMT inhibitors (such as entacapone) are used to prolong the effect of levodopa, helping to manage motor fluctuations and reduce “off” periods.

Challenges and Considerations:

While these medications are effective in managing motor symptoms, their effectiveness can diminish over time as the disease progresses, leading to more frequent “off” periods where symptoms are less controlled. Adjustments in medication regimens, including adding new medications like Gocovri (for dyskinesia) or newer drugs like tavapadon (currently in trials), are often needed as the disease advances.

Additionally, the management of side effects, such as nausea, insomnia, and potential cognitive impacts, is crucial. In Australia, the management of Parkinson’s disease often involves a multidisciplinary approach, including physical therapy and exercise, which are also key components in maintaining mobility and quality of life.

Overall, while medications are highly effective in the early and middle stages of Parkinson’s disease, ongoing adjustments and a comprehensive care plan are essential to managing symptoms as the disease progresses (RACGP) (Monash Health) (Parkinson’s Foundation).

Jodi Knapp